Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), today announced that the company will present insights into its lead cancer metabolism and inborn errors of metabolism (IEM) programs at the 2013 American Society of Hematology (ASH) Annual Meeting, taking place December 7-10, 2013 in New Orleans.
Help employers find you! Check out all the jobs and post your resume.
